Ann: Zelda Granted Approval for Opioid Reduction Trial, page-147

yeah look i agree

zeliras story like zeldas story sounds promising and includes deliverables that offer the potential of a multi bagger.

the outcomes investors have aligned them selves with no longer sit on the comfortable side of a cash balance.

the risk remains zelira may continue with this unclear path/ timeline in 2020.

if zelira does not deliver on its clearly articulated timeine (in its faviroute word being) a 'rapid' fasion and the language shifts from end of 19 and q1 to
h2 and end of 2020 then well - it is what it is.

the story sounds promising and beleivable thats why we are here

good luck.

in saying that if the newly formed zelira does a complete 180 and actually starts delivering rapid material developments then its on like donkey kong

heres hoping thats what the road from jan 2020 looks like.

but yeah - who bloody knows